• Press Releases
  • News

Press Release | 21 Oct, 2022

Revenue growth of 4% QoQ Regulated markets led the growth

Read more

Press Release | 04 Aug, 2022

PAT growth of 7.7% YoY for Q1 FY23 CVS and CNS therapies lead the growth of the generic API portfolio

Read more

Press Release | 20 April, 2022

Glenmark Life Sciences reports revenue growth of 10% YoY for Q4 FY22; 12.6% for the full year, FY22

Read more

Press Release | 8 February, 2022

Glenmark Life Sciences reports revenue growth of 4.5% and PAT growth of 11.1% YoY for Q3 FY22

Read more

Press Release | 10 November, 2021

Glenmark Life Sciences reports revenue growth of 7.9% and PAT growth of 59.0% YoY for Q2 FY22 Declares interim dividend of ₹10.5 per share

Read more

Press Release | 13 August, 2021

Glenmark Life Sciences reports revenue growth of 32.2% and PAT growth of 24.5% YoY for Q1 FY22

Read more

Press Trust of India | 07 May, 2019

Glenmark Appoints Dr. Yasir Rawjee as Chief Executive Officer of Glenmark Life Sciences, its Subsidiary for the API Business

Read more

By Abhinav Aakash | 09 Nov,2020

India Ratings Affirms Glenmark Life Sciences at 'IND AA-'; Outlook Stable

Read more

PTI | 03 Sept, 2019

Reorganisation of Glenmark into 3 entities to be concluded this fiscal: Saldanha

Read more

Press Trust of India | 07 May, 2019

Glenmark Appoints Dr. Yasir Rawjee as Chief Executive Officer of Glenmark Life Sciences, its Subsidiary for the API Business

Read more

Moneyworks4me | 02 Jan, 2019

Glenmark Pharma transfers API business to Glenmark Life Sciences

Read more

India Infoline News Service | 31 Dec, 2018

Glenmark Pharma transfers API biz to Glenmark Life Sciences

Read more